Postmenopausal osteoporosis
Conditions
Interventions
control group:Western medicine
Sponsors
The Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Eligibility
Sex/Gender
Female
Age
45 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Aged 45 to 70 years, menopause time more than 1 year; 2. All patients with bone density T value <= -2.5 measured by dual energy X-ray absorptiometry (DXA); 3. Patients who agree to enter the survey and can communicate better in language or writing.
Exclusion criteria
Exclusion criteria: 1. Patients with essential cerebrovascular diseases, liver and kidney dysfunction, and severe hematopoietic system diseases etc.; 2. Patients with malignant tumor, tuberculosis and other diseases; 3. Patients with osteoporosis due to exclusion of other factors, such as hyperparathyroidism, Paralysis, etc.; 4. With serious ruggedness, disability, etc.; 5. Patients with a history of peptic ulcer, indigestion; 6. Have received hormone replacement therapy (HRT) in the past 1 year or have taken influence on bone metabolism within 6 months before enrollment Drugs, such as bisphosphate, cortisol, calcium tablets, vitamin D, fluoride, estrogen, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bone mineral density;Insulin-like growth factor;Growth factor; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life score;PINP;Sex hormone; | — |
Countries
China
Contacts
Public ContactChen Xiuhua
The Second Affiliated Hospital of Guangzhou University of traditional Chinese Medicine
Outcome results
None listed